{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:42:42Z","timestamp":1792813362532,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","award":["101130574"],"award-info":[{"award-number":["101130574"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-148228OB-I00"],"award-info":[{"award-number":["PID2023-148228OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mib.2026.102785","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:54:33Z","timestamp":1782435273000},"page":"102785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Progress in engineered bacterial cancer therapies"],"prefix":"10.1016","volume":"92","author":[{"given":"Eva","family":"Pico-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis \u00c1","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2026.102785_bib1","unstructured":"Ferlay J., Ervik M., Lam F., Laversanne M., Colombet M., Mery L., Pi\u00f1eros M., Znaor A., Soerjomataram I., Bray F.: Global Cancer Observatory: Cancer Today (version 1.1). Edited by. Lyon, France: International Agency for Research on Cancer; 2024."},{"key":"10.1016\/j.mib.2026.102785_bib2","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.mib.2026.102785_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.mib.2026.102785_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03315-3","article-title":"Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.mib.2026.102785_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41587-025-02623-x","article-title":"The emerging landscape of engineered bacteria cancer therapies","volume":"43","author":"Ballister","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mib.2026.102785_bib6","first-page":"4537","article-title":"Tumor-targeted Salmonella as a novel anticancer vector","volume":"57","author":"Pawelek","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.mib.2026.102785_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/anae.1998.0161","article-title":"Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours","volume":"4","author":"Lambin","year":"1998","journal-title":"Anaerobe"},{"key":"10.1016\/j.mib.2026.102785_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.cgt.7700122","article-title":"Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors","volume":"7","author":"Yazawa","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.mib.2026.102785_bib9","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1158\/0008-5472.CAN-06-2618","article-title":"Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis","volume":"67","author":"Kasinskas","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.mib.2026.102785_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12934-025-02838-2","article-title":"Bacteria-based immunosuppressive tumor microenvironment reprogramming: a promising dawn in cancer therapy","volume":"24","author":"Akbariqomi","year":"2025","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.mib.2026.102785_bib11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102785_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41573-021-00285-3","article-title":"Engineering living therapeutics with synthetic biology","volume":"20","author":"Cubillos-Ruiz","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mib.2026.102785_bib13","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.chom.2023.09.006","article-title":"Build-a-bug workshop: using microbial-host interactions and synthetic biology tools to create cancer therapies","volume":"31","author":"Raman","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2026.102785_bib14","article-title":"Current status and future directions of bacteria-based immunotherapy","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.mib.2026.102785_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40291-024-00695-0","article-title":"Clostridium bacteria: harnessing tumour necrosis for targeted gene delivery","volume":"28","author":"Theys","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.mib.2026.102785_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41589-018-0056-x","article-title":"Next-generation biocontainment systems for engineered organisms","volume":"14","author":"Lee","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.mib.2026.102785_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13036-018-0105-8","article-title":"Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications","volume":"12","author":"Whitford","year":"2018","journal-title":"J Biol Eng"},{"key":"10.1016\/j.mib.2026.102785_bib18","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2026.102785_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijmm.2007.01.008","article-title":"Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice","volume":"297","author":"Stritzker","year":"2007","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.mib.2026.102785_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102785_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1256769","article-title":"The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer","volume":"13","author":"Leon-Letelier","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.mib.2026.102785_sbref21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads1630","article-title":"Leveraging dysregulated tumor metabolism for targeting anticancer bacteria","volume":"11","author":"Santos","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.mib.2026.102785_bib23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mib.2026.102785_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/acssynbio.5c00598","article-title":"Design and modeling of biosensor-driven encapsulation systems for systemic delivery of bacterial cancer therapy","volume":"15","author":"Hahn","year":"2026","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.mib.2026.102785_bib25","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1128\/IAI.00384-09","article-title":"Surface-exposed histone-like protein a modulates adherence of Streptococcus gallolyticus to colon adenocarcinoma cells","volume":"77","author":"Boleij","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2026.102785_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","article-title":"Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention","volume":"2","author":"Ho","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.mib.2026.102785_sbref26","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121709","article-title":"Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice","volume":"324","author":"Tang","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.mib.2026.102785_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/sb500252a","article-title":"Programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins","volume":"4","author":"Pi\u00f1ero-Lambea","year":"2015","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.mib.2026.102785_sbref28","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70102","article-title":"CAT-BLAST: Engineered bacteria for robust targeting and elimination of cancer-associated fibroblasts","volume":"5","author":"Xu","year":"2026","journal-title":"iMeta"},{"key":"10.1016\/j.mib.2026.102785_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrmicro.2015.3","article-title":"Pore-forming toxins: ancient, but never really out of fashion","volume":"14","author":"Dal Peraro","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2026.102785_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mt.2009.295","article-title":"Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy","volume":"18","author":"Jiang","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.mib.2026.102785_bib32","article-title":"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug","author":"Decker-Farrell","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2026.102785_sbref32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114004","article-title":"Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models","volume":"385","author":"Park","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.mib.2026.102785_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-023-01646-z","article-title":"Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor beta","volume":"25","author":"Murakami-Nishimagi","year":"2023","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.mib.2026.102785_bib35","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.devcel.2024.08.003","article-title":"Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression","volume":"59","author":"Zhang","year":"2024","journal-title":"Dev Cell"},{"key":"10.1016\/j.mib.2026.102785_bib36","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10529-024-03536-6","article-title":"Engineered probiotic E.coli Nissle 1917 for release PTEN to improve the tumor microenvironment and suppress tumor growth","volume":"46","author":"Dai","year":"2024","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.mib.2026.102785_bib37","doi-asserted-by":"crossref","first-page":"14098","DOI":"10.1073\/pnas.222539699","article-title":"Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer","volume":"99","author":"Yamada","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2026.102785_bib38","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-024-48661-y","article-title":"Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy","volume":"15","author":"Shen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102785_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/polym14040687","article-title":"Applications of the ROS-responsive thioketal linker for the production of smart nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.mib.2026.102785_bib40","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41587-024-02418-6","article-title":"Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses","volume":"43","author":"Yang","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mib.2026.102785_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mib.2026.102785_bib42","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2026.102785_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mib.2026.102785_sbref43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102785_sbref44","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn9879","article-title":"Programmable bacteria synergize with PD-1 blockade to overcome cancer cell\u2013intrinsic immune resistance mechanisms","volume":"9","author":"Li","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.mib.2026.102785_bib46","article-title":"Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy","author":"Rouanne","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2026.102785_sbref46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102785_sbref47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.mib.2026.102785_sbref48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.abp9563","article-title":"Engineered skin bacteria induce antitumor T cell responses against melanoma","volume":"380","author":"Chen","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102785_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26367-9","article-title":"Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases","volume":"12","author":"Raman","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102785_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1228532","article-title":"Intracellular Salmonella delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity","volume":"14","author":"Raman","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.mib.2026.102785_sbref51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ymthe.2024.12.038","article-title":"Controlling intracellular protein delivery, tumor colonization and tissue distribution using the master regulator flhDC in a clinically relevant \u2206sseJ Salmonella strain","volume":"33","author":"Raman","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.mib.2026.102785_bib53","article-title":"Synthetic bacteria with programmed cell targeting and protein injection suppress tumor growth in vivo","author":"Asensio-Calavia","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2026.102785_bib54","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acssynbio.5b00080","article-title":"Engineering the controlled assembly of filamentous injectisomes in E. coli K-12 for protein translocation into mammalian cells","volume":"4","author":"Ruano-Gallego","year":"2015","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.mib.2026.102785_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.14328","article-title":"A tuneable genetic switch for tight control of tac promoters in Escherichia coli boosts expression of synthetic injectisomes","volume":"17","author":"Asensio-Calavia","year":"2024","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.mib.2026.102785_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep41252","article-title":"Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells","volume":"7","author":"Zahaf","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mib.2026.102785_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00963","article-title":"Pseudomonas Exotoxin A: optimized by evolution for effective killing","volume":"6","author":"Michalska","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mib.2026.102785_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133073","article-title":"BCG in bladder cancer immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mib.2026.102785_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003939","article-title":"FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer","volume":"10","author":"Zhang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.mib.2026.102785_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2018.12.097","article-title":"The immunotherapeutic effects of recombinant Bacillus Calmette-Guerin resistant to antimicrobial peptides on bladder cancer cells","volume":"509","author":"Cho","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mib.2026.102785_bib61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4111\/icu.20220293","article-title":"Efficacy of recombinant Bacillus Calmette-Gu\u00e9rin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model","volume":"64","author":"Choi","year":"2023","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.mib.2026.102785_bib62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CJI.0000000000000325","article-title":"A Phase I, dose escalation, single dose trial of oral attenuated Salmonella typhimurium containing human IL-2 in patients with metastatic gastrointestinal cancers","volume":"43","author":"Gniadek","year":"2020","journal-title":"J Immunother"},{"key":"10.1016\/j.mib.2026.102785_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx393.041","article-title":"515P - First-in-human Phase I study of bacterial RNA interference therapeutic CEQ508 in patients with familial adenomatous polyposis (FAP)","volume":"28","author":"Trieu","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mib.2026.102785_bib64","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered E. coli nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mib.2026.102785_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.201502074","article-title":"A bacterial type III secretion-based protein delivery tool for broad applications in cell biology","volume":"211","author":"Ittig","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.mib.2026.102785_bib66","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41551-025-01476-8","article-title":"Engineered bacteria launch and control an oncolytic virus","volume":"10","author":"Singer","year":"2026","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.mib.2026.102785_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313389","article-title":"Engineered microorganisms for advancing tumor therapy","volume":"36","author":"Jia","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.mib.2026.102785_bib68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chom.2023.01.013","article-title":"Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance","volume":"31","author":"Zhang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2026.102785_bib69","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527426000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527426000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:39:24Z","timestamp":1790152764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527426000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":69,"alternative-id":["S1369527426000792"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2026.102785","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in engineered bacterial cancer therapies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2026.102785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102785"}}